-
3
-
-
80052267194
-
-
Food and Drug Administration (FDA) Guidance for industry. Rockville, Maryland. Available at:
-
Food and Drug Administration (FDA). 2010. S9 non clinical evaluation for anticancer pharmaceuticals. Guidance for industry. Rockville, Maryland. Available at:.
-
(2010)
S9 non clinical evaluation for anticancer pharmaceuticals
-
-
-
4
-
-
0025360796
-
Pharmacologically guided phase I clinical trials based upon preclinical drug development
-
Collins JM, Grieshaber CK, Chabner BA. 1990. Pharmacologically guided phase I clinical trials based upon preclinical drug development. J Natl Cancer Inst 82:1321-1326.
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 1321-1326
-
-
Collins, J.M.1
Grieshaber, C.K.2
Chabner, B.A.3
-
5
-
-
0028792083
-
First-time-in-human dose selection: Allometric thoughts and perspectives
-
Boxenbaum H, DiLea C. 1995. First-time-in-human dose selection: Allometric thoughts and perspectives. J Clin Pharmacol 35:943-956.
-
(1995)
J Clin Pharmacol
, vol.35
, pp. 943-956
-
-
Boxenbaum, H.1
DiLea, C.2
-
6
-
-
33747154776
-
Prediction of human drug clearance from animal data: Application of the rule of exponent and fu corrected intercept method (FCIM)
-
Mahmood I. 2006. Prediction of human drug clearance from animal data: Application of the rule of exponent and fu corrected intercept method (FCIM). J Pharm Sci 95:1810-1821.
-
(2006)
J Pharm Sci
, vol.95
, pp. 1810-1821
-
-
Mahmood, I.1
-
7
-
-
0036379076
-
Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches
-
Mahmood I. 2002. Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches. Drug Metab Drug Inter 19:49-64.
-
(2002)
Drug Metab Drug Inter
, vol.19
, pp. 49-64
-
-
Mahmood, I.1
-
8
-
-
0029828960
-
Interspecies scaling: Predicting clearance of drugs in humans. Three different approaches
-
Mahmood I, Balian JD. 1996. Interspecies scaling: Predicting clearance of drugs in humans. Three different approaches. Xenobiotica 26:887-895.
-
(1996)
Xenobiotica
, vol.26
, pp. 887-895
-
-
Mahmood, I.1
Balian, J.D.2
-
9
-
-
0036356378
-
Interspecies scaling: Predicting oral clearance in humans
-
Mahmood I. 2002. Interspecies scaling: Predicting oral clearance in humans. Am J Ther 9:35-42.
-
(2002)
Am J Ther
, vol.9
, pp. 35-42
-
-
Mahmood, I.1
-
10
-
-
2442680354
-
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance
-
Ward KW, Smith BR. 2004. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance. Drug Metab Dispos 32:603-611.
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 603-611
-
-
Ward, K.W.1
Smith, B.R.2
-
11
-
-
34748919740
-
Interspecies prediction of human drug clearance based on scaling data from one or two animal species
-
Tang H, Hussain A, Leal M, Mayersohn M, Fluhler E. 2007. Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Drug Metab Dispos 35:1886-1893.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 1886-1893
-
-
Tang, H.1
Hussain, A.2
Leal, M.3
Mayersohn, M.4
Fluhler, E.5
-
12
-
-
23944515735
-
A novel method for prediction of human drug clearance by allometric scaling
-
Tang H, Mayersohn M. 2005. A novel method for prediction of human drug clearance by allometric scaling. Drug Metab Dispos 33:1297-1303.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 1297-1303
-
-
Tang, H.1
Mayersohn, M.2
-
13
-
-
0345306618
-
Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: Oral clearance
-
Wajima T, Fukumura K, Yano Y, Oguma T. 2003. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: Oral clearance. J Pharm Sci 92:2427-2440.
-
(2003)
J Pharm Sci
, vol.92
, pp. 2427-2440
-
-
Wajima, T.1
Fukumura, K.2
Yano, Y.3
Oguma, T.4
-
14
-
-
0032733974
-
Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes
-
Obach RS. 1999. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350-1359.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 1350-1359
-
-
Obach, R.S.1
-
15
-
-
46449114275
-
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds
-
Obach RS, Lombardo F, Waters NJ. 2008. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos 36:1385-1405.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 1385-1405
-
-
Obach, R.S.1
Lombardo, F.2
Waters, N.J.3
-
16
-
-
37149008003
-
Predicting oral clearance in humans. How close can we get with allometry
-
Sinha VK, De Buck SS, Fenu LA, Smit JW, Nijsen M, Gilissen RA, Van Peer A, Lavrijsen K, Mackie CE. 2008. Predicting oral clearance in humans. How close can we get with allometry. Clin Pharmacokinet 47:35-45.
-
(2008)
Clin Pharmacokinet
, vol.47
, pp. 35-45
-
-
Sinha, V.K.1
De, B.S.2
Fenu, L.A.3
Smit, J.W.4
Nijsen, M.5
Gilissen, R.A.6
Van Peer, A.7
Lavrijsen, K.8
Mackie, C.E.9
-
17
-
-
65449166750
-
Prediction of human pharmacokinetics from preclinical information: Comparative accuracy of quantitative prediction approaches
-
Hosea NA, Collard WT, Cole S, Maurer TS, Fang RX, Jones H, Kakar SM, Nakai Y, Smith BJ, Webster R, Beaumont K. 2009. Prediction of human pharmacokinetics from preclinical information: Comparative accuracy of quantitative prediction approaches. J Clin Pharm 49:513-33.
-
(2009)
J Clin Pharm
, vol.49
, pp. 513-533
-
-
Hosea, N.A.1
Collard, W.T.2
Cole, S.3
Maurer, T.S.4
Fang, R.X.5
Jones, H.6
Kakar, S.M.7
Nakai, Y.8
Smith, B.J.9
Webster, R.10
Beaumont, K.11
-
18
-
-
80052273956
-
Prediction of human drug clearance from two species: A comparison of several allometric methods
-
Goteti K, Garner CE, Mahmood I. 2009. Prediction of human drug clearance from two species: A comparison of several allometric methods. J Pharm Sci 10:1-13.
-
(2009)
J Pharm Sci
, vol.10
, pp. 1-13
-
-
Goteti, K.1
Garner, C.E.2
Mahmood, I.3
-
19
-
-
33646124969
-
A novel strategy for physiologically based predictions of human pharmacokinetics
-
Jones HM, Parrott N, Jorga K, Lave T. 2006. A novel strategy for physiologically based predictions of human pharmacokinetics. Clin Pharmacokinet 45(5):511-542.
-
(2006)
Clin Pharmacokinet
, vol.45
, Issue.5
, pp. 511-542
-
-
Jones, H.M.1
Parrott, N.2
Jorga, K.3
Lave, T.4
-
20
-
-
34748925493
-
Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs
-
De Buck SS, Sinha VK, Fenu LA, Nijsen MJ, Mackie CE, Gilissen RA. 2007. Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs. Drug Metab Dispos 35:1766-1780.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 1766-1780
-
-
De, B.S.1
Sinha, V.K.2
Fenu, L.A.3
Nijsen, M.J.4
Mackie, C.E.5
Gilissen, R.A.6
-
21
-
-
34548393250
-
Prediction of human pharmacokinetics: Evaluation of methods for prediction of volume of distribution
-
Fagerholm U. 2007. Prediction of human pharmacokinetics: Evaluation of methods for prediction of volume of distribution. J Pharm Pharmacol 59:1181-1190.
-
(2007)
J Pharm Pharmacol
, vol.59
, pp. 1181-1190
-
-
Fagerholm, U.1
-
22
-
-
34447312263
-
Prediction of human pharmacokinetics: Evaluation of methods for prediction of hepatic metabolic clearance
-
Fagerholm U. 2007. Prediction of human pharmacokinetics: Evaluation of methods for prediction of hepatic metabolic clearance. J Pharm Pharmacol 59:803-828.
-
(2007)
J Pharm Pharmacol
, vol.59
, pp. 803-828
-
-
Fagerholm, U.1
-
23
-
-
34447337731
-
Prediction of human pharmacokinetics: Gastrointestinal absorption
-
Fagerholm U. 2007. Prediction of human pharmacokinetics: Gastrointestinal absorption. J Pharm Pharmacol 59:905-916.
-
(2007)
J Pharm Pharmacol
, vol.59
, pp. 905-916
-
-
Fagerholm, U.1
-
24
-
-
77957344287
-
Prediction of human metabolic clearance from in vitro systems: Retrospective analysis and prospective view
-
Halifax D, Foster JA, Houston BJ. 2010. Prediction of human metabolic clearance from in vitro systems: Retrospective analysis and prospective view. Pharm Res 27:2150-2161.
-
(2010)
Pharm Res
, vol.27
, pp. 2150-2161
-
-
Halifax, D.1
Foster, J.A.2
Houston, B.J.3
-
25
-
-
80052267476
-
PhRMA PISC initiative on predictive models of human pharmacokinetics. 2. Comparative assessment of prediction methods of human volume of distribution
-
submitted as a companion paper).
-
Jones RDO, Jones HM, Rowland M, Gibson CR, Yates JWT, Chien JY, Ring BJ, Adkison KK, Ku MS, He H, Vuppugalla R, Marathe P, Fisher V, Dutta S, Sinha VK, Björnsson T, Lavé T, Poulin P. 2011. PhRMA PISC initiative on predictive models of human pharmacokinetics. 2. Comparative assessment of prediction methods of human volume of distribution. J Pharm Sci (submitted as a companion paper).
-
(2011)
J Pharm Sci
-
-
Jones, R.D.O.1
Jones, H.M.2
Rowland, M.3
Gibson, C.R.4
Yates, J.W.T.5
Chien, J.Y.6
Ring, B.J.7
Adkison, K.K.8
Ku, M.S.9
He, H.10
Vuppugalla, R.11
Marathe, P.12
Fisher, V.13
Dutta, S.14
Sinha, V.K.15
Björnsson, T.16
Lavé, T.17
Poulin, P.18
-
26
-
-
80052268294
-
PhRMA PISC initiative on predictive models of human pharmacokinetics. 3. Comparative assessment of prediction methods of human clearance
-
submitted as a companion paper).
-
Ring B, Chien JY, Adkison KK, Jones HM, Rowland M, Jones RDO, Yates JWT, Ku MS, Gibson CR, He H, Vuppugalla R, Marathe M, Fisher V, Dutta S, Sinha V, Björnsson T, Lavé T, Poulin P. 2011. PhRMA PISC initiative on predictive models of human pharmacokinetics. 3. Comparative assessment of prediction methods of human clearance. J Pharm Sci (submitted as a companion paper).
-
(2011)
J Pharm Sci
-
-
Ring, B.1
Chien, J.Y.2
Adkison, K.K.3
Jones, H.M.4
Rowland, M.5
Jones, R.D.O.6
Yates, J.W.T.7
Ku, M.S.8
Gibson, C.R.9
He, H.10
Vuppugalla, R.11
Marathe, M.12
Fisher, V.13
Dutta, S.14
Sinha, V.15
Björnsson, T.16
Lavé, T.17
Poulin, P.18
-
27
-
-
80052258840
-
PhRMA PISC initiative on predictive models of human pharmacokinetics. 4. Prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach
-
submitted as a companion paper).
-
Vuppugalla R, Marathe P, He H, Jones RDO, Yates JWT, Jones HM, Gibson CR, Chien JY, Ring BJ, Adkison KK, Ku MS, Fisher V, Dutta S, Sinha VK, Björnsson T, Lavé T, Poulin P. 2011. PhRMA PISC initiative on predictive models of human pharmacokinetics. 4. Prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach. J Pharm Sci (submitted as a companion paper).
-
(2011)
J Pharm Sci
-
-
Vuppugalla, R.1
Marathe, P.2
He, H.3
Jones, R.D.O.4
Yates, J.W.T.5
Jones, H.M.6
Gibson, C.R.7
Chien, J.Y.8
Ring, B.J.9
Adkison, K.K.10
Ku, M.S.11
Fisher, V.12
Dutta, S.13
Sinha, V.K.14
Björnsson, T.15
Lavé, T.16
Poulin, P.17
-
28
-
-
80052262709
-
PhRMA PISC initiative on predictive models of human pharmacokinetics. 5. Prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic (PBPK) approach
-
submitted as a companion paper).
-
Poulin P, Jones RDO, Jones HM, Gibson CR, Rowland M, Chien JY, Ring BJ, Adkison KK, Ku MS, He H, Vuppugalla R, Marathe P, Fisher V, Dutta S, Sinha VK, Björnsson T, Lavé T, Yates JWT. 2011. PhRMA PISC initiative on predictive models of human pharmacokinetics. 5. Prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic (PBPK) approach. J Pharm Sci (submitted as a companion paper).
-
(2011)
J Pharm Sci
-
-
Poulin, P.1
Jones, R.D.O.2
Jones, H.M.3
Gibson, C.R.4
Rowland, M.5
Chien, J.Y.6
Ring, B.J.7
Adkison, K.K.8
Ku, M.S.9
He, H.10
Vuppugalla, R.11
Marathe, P.12
Fisher, V.13
Dutta, S.14
Sinha, V.K.15
Björnsson, T.16
Lavé, T.17
Yates, J.W.T.18
-
29
-
-
71649089269
-
Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods
-
Poulin P, Theil FP. 2009. Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods. J Pharm Sci 98:4941-4961.
-
(2009)
J Pharm Sci
, vol.98
, pp. 4941-4961
-
-
Poulin, P.1
Theil, F.P.2
-
30
-
-
34347396549
-
A unified approach for assessing agreement for continuous and categorical data
-
Lin L, Hedayat AS, Wu W. 2007. A unified approach for assessing agreement for continuous and categorical data. J Biopharm Stat 17:629-652.
-
(2007)
J Biopharm Stat
, vol.17
, pp. 629-652
-
-
Lin, L.1
Hedayat, A.S.2
Wu, W.3
-
31
-
-
84975207356
-
A note on the concordance correlation coefficient
-
Lin L. 2000. A note on the concordance correlation coefficient. Biometrics 56:324-325.
-
(2000)
Biometrics
, vol.56
, pp. 324-325
-
-
Lin, L.1
-
33
-
-
33846176619
-
A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan
-
Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. 2006. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharmacol 3:631-643.
-
(2006)
Mol Pharmacol
, vol.3
, pp. 631-643
-
-
Takagi, T.1
Ramachandran, C.2
Bermejo, M.3
Yamashita, S.4
Yu, L.X.5
Amidon, G.L.6
-
34
-
-
3242728351
-
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification
-
Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennerna SH, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. 2004. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharmacol 1:85-96.
-
(2004)
Mol Pharmacol
, vol.1
, pp. 85-96
-
-
Kasim, N.A.1
Whitehouse, M.2
Ramachandran, C.3
Bermejo, M.4
Lennerna, S.H.5
Hussain, A.S.6
Junginger, H.E.7
Stavchansky, S.A.8
Midha, K.K.9
Shah, V.P.10
Amidon, G.L.11
-
36
-
-
3843097202
-
Classification of orally administered drugs on the World Health Organization model of essential medicines according to the biopharmaceutics classification system
-
Lindenberg M, Kopp S, Dressman JB. 2004. Classification of orally administered drugs on the World Health Organization model of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 58:265-278.
-
(2004)
Eur J Pharm Biopharm
, vol.58
, pp. 265-278
-
-
Lindenberg, M.1
Kopp, S.2
Dressman, J.B.3
-
37
-
-
17644380257
-
Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
-
Wu CY, Benet LZ. 2005. Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 22:11-23.
-
(2005)
Pharm Res
, vol.22
, pp. 11-23
-
-
Wu, C.Y.1
Benet, L.Z.2
-
38
-
-
51249121664
-
An oral formulation decision tree based on the biopharmaceutical classification system for first in human clinical trials
-
Ku SM. 2006. An oral formulation decision tree based on the biopharmaceutical classification system for first in human clinical trials. Gattefossé Bull Tech 99:89-92.
-
(2006)
Gattefossé Bull Tech
, vol.99
, pp. 89-92
-
-
Ku, S.M.1
-
39
-
-
80052272017
-
-
World Health Organization (WHO) 14th ed. Geneva, Switzerland. Available at:
-
World Health Organization (WHO). 2005. List of essential drugs. 14th ed. Geneva, Switzerland. Available at:.
-
(2005)
List of essential drugs
-
-
-
40
-
-
0031024171
-
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
-
Lipiniski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25.
-
(1997)
Adv Drug Deliv Rev
, vol.23
, pp. 3-25
-
-
Lipiniski, C.A.1
Lombardo, F.2
Dominy, B.W.3
Feeney, P.J.4
-
41
-
-
0002041834
-
Multivariate pharmaceutical profiling for drug discovery
-
Kerns EH, Di L. 2002. Multivariate pharmaceutical profiling for drug discovery. Curr Top Med Chem 2:87-98.
-
(2002)
Curr Top Med Chem
, vol.2
, pp. 87-98
-
-
Kerns, E.H.1
Di, L.2
-
44
-
-
0027155519
-
Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment
-
Smith DA. 1993. Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment. Eur J Drug Metab Pharmacokinet 18:31-39.
-
(1993)
Eur J Drug Metab Pharmacokinet
, vol.18
, pp. 31-39
-
-
Smith, D.A.1
-
45
-
-
16844366148
-
Review of UCN-01 development: A lesson in the importance of clinical pharmacology
-
Fuse E, Kuwabara T, Sparreboom A, Sausville EA, Figg WD. 2005. Review of UCN-01 development: A lesson in the importance of clinical pharmacology. J Clin Pharmacol 45:394-403.
-
(2005)
J Clin Pharmacol
, vol.45
, pp. 394-403
-
-
Fuse, E.1
Kuwabara, T.2
Sparreboom, A.3
Sausville, E.A.4
Figg, W.D.5
-
46
-
-
70350255269
-
-
Food and Drug Administration (FDA) Guidance for the Industry. Rockville, Maryland. Available at:
-
Food and Drug Administration (FDA). 2008. Safety testing of drug metabolites. Guidance for the Industry. Rockville, Maryland. Available at:.
-
(2008)
Safety testing of drug metabolites
-
-
-
47
-
-
70350348642
-
To scale or not to scale: The principles of dose extrapolation
-
Sharma V, McNeill JH. 2009. To scale or not to scale: The principles of dose extrapolation. Br J Pharmacol 157:907-921.
-
(2009)
Br J Pharmacol
, vol.157
, pp. 907-921
-
-
Sharma, V.1
McNeill, J.H.2
|